TET2-Mediated Epigenetic Reprogramming of Breast Cancer Cells Impairs Lysosome Biogenesis

The authors sought to alter transcriptional programs by enforcing expression of the catalytic domain of the methylcytosine dioxygenase TET2 in breast cancer cells.